Pliant shares plummet as Phase 2b lung fibrosis study paused

Pliant Therapeutics has slammed the brakes on enrollment and dosing in a mid-stage study of its lung disease candidate in a scenario that some analysts say they have “never seen before.” The West Coast biotech ...

Feb 10, 2025 - 13:16

Pliant shares plummet as Phase 2b lung fibrosis study paused

Pliant Therapeutics has slammed the brakes on enrollment and dosing in a mid-stage study of its lung disease candidate in a scenario that some analysts say they have “never seen before.” The West Coast biotech ...